The Competition Commission of India is reviewing the proposed acquisition of Sahrudaya Health Care Pvt. Ltd., a multi-specialty hospital network, by Maybach Asia Holdings II Pte. Ltd., an SPV owned by KKR & Co. Inc. subsidiaries.
The Competition Commission of India (CCI) is currently reviewing the acquisition of 100% of the equity share capital of Sahrudaya Health Care Pvt. Ltd., a multi-specialty hospital network with 28 hospitals/units and approximately 4800 beds across south and west India, by Maybach Asia Holdings II Pte. Ltd.
The proposed combination involves acquisition of the Target, which provides comprehensive care across more than 80 clinical specialties including cardiology, neurology, gastroenterology, nephrology, oncology, orthopedics, critical care, women's health and other medical and surgical specialties.
The Acquirer, Maybach Asia Holdings II Pte. Ltd., is a special purpose vehicle (SPV) incorporated solely for the purpose of the Proposed Transaction. It is indirectly owned by investment funds, vehicles and/or accounts advised and managed by various subsidiaries of KKR & Co. Inc.
Source:
Press Information Bureau
